Apnimed Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	120.15	38.47	8.01
Revenue Growth (YoY)	-	380.12%	-
Gross Profit	120.15	38.47	8.01
Selling, General & Admin	-	23.49	21.5
Research & Development	-	62.1	97.38
Other Operating Expenses	0	6.69	3.37
Operating Expenses	-	92.29	122.25
Operating Income	41.34	-53.82	-114.23
Interest Expense (Income)	-1.2	-1.41	-5.68
Other Expense (Income)	74.36	75.79	2.7
Pretax Income	-31.83	-128.19	-111.25
Income Tax	0	-	0.05
Net Income	-31.83	-128.19	-111.31
Free Cash Flow	-69.19	-77.83	-110.28
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	34.41%	-139.91%	-1425.79%
Profit Margin	-26.49%	-333.25%	-1389.23%
Free Cash Flow Margin	-57.59%	-202.33%	-1376.42%
EBITDA	-33	-129.58	-116.92
EBITDA Margin	-27.46%	-336.85%	-1459.25%
Depreciation & Amortization	0.03	0.03	0.02
EBIT	-33.03	-129.6	-116.94
EBIT Margin	-27.49%	-336.92%	-1459.54%